Fig. 5
From: Multi-pathway targeted therapy of MASH-HCC using miR-22
The spatiotemporal effects of miR-22 in HCC. Molecular signatures identified by early and late injection of miR-22 in HCC mice. Venn diagrams showing expressed gene numbers altered by miR-22 treatments. Reactome pathway analysis identified significant pathways (FDR < 0.1, minimum fold change of 1.5) in three locations: A inside the tumor, B at the tumor margin, C in nontumor areas